Give a short and critical explanation of the rationale of using fluvoxamine (a selective serotonin reuptake inhibitor (SSRI) in the treatment of Covid patients. Your answer must be properly and appropriately referenced (in-text references as well). 

Fluvoxamine is a selective serotonin reuptake inhibitor (SRRI), used in OCD (over compulsive disorder) and depression. In COVID-19 patients Fluvoxamine was found to reduce expression of inflammatory genes. In a study, when SARS-CoV-2 broke out, 65 participant who tested positive opted to take Fluvoxamine and after 14 days the patients who had lower anxiety levels, felt less fatigued and could concentrate better (NIH, 2021:204). Fluvoxamine lowers inflammatory cytokine production. It also has an antiviral effect reducing the ability to enter cells' lysosomes (Lianna Matt Mclemon, 2021:1).

• https://www.covid19treatmentguidelines.nih.gov/therapies/immunomodulators/fluvoxamine/
• https://www.cidrap.umn.edu/news-perspective/2021/04/ocd-drug-spotlighted-potential-covid-19-treatment